Tiazac appeals court ruling
Executive Summary
Miami federal court ruling in favor of Andrx upheld on appeal. The court ruled that Andrx' generic version of Biovail/Forest's Tiazac (diltiazem) does not infringe Biovail's patent No. 5,529,791. Biovail listed a patent (No. 6,162,463) in January, triggering new litigation (1"The Pink Sheet" Feb. 5, p. 27)